UNSPSC 51351518: Alfasone or algestone or alphasone

This classification denotes a therapeutic progestin with the molecular formula C21H30O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3JEB53B3WT, chemically known as 16alpha,17-Dihydroxypregn-4-ene-3,20-dione but generally known as algestone, which bears US NIH Compound Identifier 11687. European Medicines Agency schedules Algestone acetophenide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05321MIG. SMILES: CC(=O)C1(C(CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O)O.

UNSPSC 51351518 Alfasone or algestone or alphasone is a Commodity code covering a specific pharmaceutical steroid compound used in state and local healthcare procurement, though recent state and local contract opportunities show minimal activity under this code. State and local health departments, correctional facilities, and public hospital systems occasionally procure steroid medications including this formulation as part of routine pharmaceutical supply contracts, but the specificity of this compound results in narrow demand concentrated in larger public healthcare systems with specialized treatment protocols.

The source provides no recent state and local contract opportunities tagged to this code, and no issuing bodies, geographic regions, or representative solicitations are identifiable from available data. Procurement professionals monitoring this code should treat it as a niche pharmaceutical line item unlikely to generate standalone solicitations; when present, it typically appears as a line-item option within broader pharmaceutical supply agreements or group purchasing organization (GPO) contracts that state hospital networks or correctional health services maintain. Activity, if any, would surface through state health department RFPs for institutional pharmaceutical supply or through cooperative purchasing vehicles serving public healthcare networks.